DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Burtness B, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro GJr.
Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): A randomised, open-label, phase 3 study.
Lancet 2019;
394: 1915-28
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.